Mountain View, CA, United States of America

Diana Cepeda

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Adverum Biotechnologies, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Diana Cepeda. Retrieved from https://idiyas.com/inventor/diana-cepeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Diana Cepeda: Innovator in Gene Therapy

Introduction

Diana Cepeda is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of gene therapy, particularly in the development of adeno-associated virus (AAV) technologies. Her work focuses on innovative solutions for delivering therapeutic agents to treat various diseases.

Latest Patents

Diana holds a patent for "Variant AAV capsids for intravitreal delivery." This patent includes variant adeno-associated virus (AAV) capsid proteins and recombinant AAV virions that possess one or more variant AAV capsid proteins. The patent also outlines compositions and methods for utilizing these recombinant AAV virions, which can be employed for the treatment or prophylaxis of diseases or disorders. She has 1 patent to her name.

Career Highlights

Diana is currently employed at Adverum Biotechnologies, Inc., where she continues to advance her research in gene therapy. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Diana collaborates with talented professionals, including Annahita Keravala and Mehdi Gasmi, who contribute to her research efforts and help drive innovation within the company.

Conclusion

Diana Cepeda's work in developing AAV technologies showcases her commitment to improving therapeutic delivery systems. Her contributions are paving the way for advancements in gene therapy and have the potential to impact many lives positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…